Cytodyn board of directors
WebJul 24, 2024 · Paul Rosenbaum, CEO of SWR Corp., is no stranger to shareholder activism. He’s leading a group of investors calling for change at CytoDyn. WebJul 27, 2024 · Jul 27, 2024 CytoDyn, which has been fending off lawsuits from directors and shareholders for more than a year, now faces a new challenge from an investor group that is trying to remake the...
Cytodyn board of directors
Did you know?
WebOct 20, 2024 · VANCOUVER, Wash., Oct. 20, 2024 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced additional changes in its Board of Directors (the “Board”). Mr. WebJul 13, 2024 · VANCOUVER, Washington, July 13, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced the appointment of Dr. Cyrus Arman as President effective July 9, 2024. Dr.
WebOct 28, 2024 · Nader Pourhassan, CytoDyn's president and CEO, said he's confident that the company will achieve enough votes for its slate of directors and the 200 million additional shares it wants to issue.... WebJul 24, 2024 · Company: CytoDyn Inc. (CYDY) Business: CytoDyn is a late-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel ...
WebAug 2, 2024 · BOSTON, Aug 2 (Reuters) - Biotechnology firm CytoDyn CYDY.PK, which is working on coronavirus treatments, is pushing back against activists trying to seize control of its board by declaring... WebAug 13, 2024 · VANCOUVER, Washington, Aug. 13, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB:CYDY), a biotechnology company developing a novel …
WebOct 20, 2024 · VANCOUVER, Wash., Oct. 20, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a biotechnology company developing leronlimab, a CCR5 antagonist …
WebApr 20, 2024 · Dr. Scott Kelly, Chairman of the Board, Chief Medical Officer and Head of Business Development, added, “We are very pleased Dr. Patel has joined our Board. dewalt utility knifeWebApr 11, 2024 · CytoDyn Appoints Scott A. Kelly, M.D. to Its Board of Directors. VANCOUVER, Washington, April 11, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. … church of jesus christ calgaryWebJun 1, 2012 · CYTODYN INC. NON-EMPLOYEE BOARD OF DIRECTORS COMPENSATION EFFECTIVE JUNE 1, 2012 A. Annual compensation payable to a non … church of jesus christ campsitesWebDirector Mr. Dunlap has over 25 years’ experience in finance and operations leadership, developing significant expertise in strategy setting, improving operational efficiency and effectiveness, fundraising and investor relations, financial reporting and … Dr. Cunningham, a certified Project Management Professional with … church of jesus christ cannerychurch of jesus christ callingsWebJan 25, 2024 · The Board of Directors terminated the employment of Nader Z. Pourhassan, Ph.D., as President and CEO of the Company and he is no longer a member of the Board of Directors, effective January... church of jesus christ campingWebAug 2, 2024 · VANCOUVER, Washington-- ( BUSINESS WIRE )--CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company, announced today that the director nominations submitted... dewalt utility knife blade change